• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Ingevity announces appointment of David H. Li as president and CEO

    3/10/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials
    Get the next $NGVT alert in real time by email

    Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier

    Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity's board.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310043042/en/

    Li has more than 25 years of experience in the specialty materials industry. He most recently served as CEO, president and a member of the board of CMC Materials, Inc., a global supplier of advanced materials focused on the semiconductor and energy industries, prior to its sale to Entegris, Inc. in 2022.

    "David (Dave) has a broad and proven track record of repositioning businesses across product lines and geographies to achieve substantial growth, strong financial performance and outstanding stockholder returns," said Ingevity's board chair, Jean Blackwell. "These accomplishments and his ability to drive strategic execution and organizational excellence across global organizations make Dave the ideal CEO to lead Ingevity and enable the company to realize its full potential as a world class specialty chemicals and materials manufacturer."

    "It is an honor to step into the president and CEO role at this pivotal time and have the opportunity to build on the strong momentum the Ingevity board and management team have created," said Li. "Over the course of my career, success has been fueled by building high-performing teams and reshaping portfolios to solve customers' greatest challenges. I look forward to leveraging my experience to unlock the value within Ingevity and position the company for long-term profitable growth and superior value creation."

    "On behalf of the board, I would like to thank Luis for his service to Ingevity as interim president and CEO," said Blackwell. "Under his leadership, Ingevity has undertaken a number of strategic initiatives, including a proactive approach to portfolio management, that have resulted in improved operational performance and free cash flow generation. His work as interim CEO made his input on this hiring decision even more valuable, and we look forward to continuing to benefit from Luis's experience and leadership as a member of the Ingevity board."

    About David H. Li

    Li served as chief executive officer, president and a member of the board of CMC Materials from January 2015 to July 2022. Over his tenure and at the time of CMC's sale to Entegris, the company had delivered a four-fold return to stockholders and reported record revenue of $1.2 billion and adjusted EBITDA margin of 30 percent, in the top-tier of industry peers.

    Before being named chief executive officer and president, Li served as CMC's vice president of the Asia Pacific region for seven years. Prior to that, he held various senior leadership and management positions at CMC, including in the areas of product line management, operations, supply chain and investor relations.

    Ingevity: Purify, Protect and Enhance

    Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and road technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components. Headquartered in North Charleston, South Carolina, Ingevity operates from 31 countries around the world and employs approximately 1,600 people. The company's common stock is traded on the New York Stock Exchange (NYSE:NGVT). For more information, visit ingevity.com.

    About Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," "believes," "anticipates" or similar expressions. Forward-looking statements may include, without limitation, the potential benefits of any leadership transition; expected financial positions, guidance, results of operations and cash flows; financing plans; business strategies and expectations. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, such factors detailed from time to time in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K as well as in our other filings with the SEC. These forward-looking statements speak only to management's beliefs as of the date of this press release. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.

    Additional Information and Where to Find It

    In connection with Ingevity's 2025 annual meeting of stockholders (the "2025 Annual Meeting"), Ingevity filed on March 10, 2025 with the Securities and Exchange Commission ("SEC") a preliminary proxy statement on Schedule 14A (the "Proxy Statement"), containing a form of WHITE proxy card. The Proxy Statement is in preliminary form and Ingevity intends to file and mail to stockholders of record entitled to vote at the 2025 Annual Meeting a definitive proxy statement and other documents, including a WHITE proxy card. This communication is not a substitute for any proxy statement or other document that Ingevity has filed or may file with the SEC in connection with any solicitation by Ingevity. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY INGEVITY AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. These documents, including the Proxy Statement (and any amendments or supplements thereto) and other documents filed by Ingevity with the SEC, are available free of charge at the SEC's website at http://www.sec.gov and at Ingevity's investor relations website at http://ir.ingevity.com.

    Participants in the Solicitation

    Ingevity, its directors and certain of its executive officers and other employees may be deemed to be participants in the solicitation of proxies from Ingevity stockholders in connection with the matters to be considered at the 2025 Annual Meeting. Information regarding such participants and their respective interests in Ingevity by security holdings or otherwise is set forth in the section entitled "Appendix C: Supplemental Information Regarding Participants in the Solicitation" in the Proxy Statement, which was filed with the SEC on March 10, 2025, and will be included in Ingevity's definitive proxy statement, once available. Additional information regarding the interests of these participants in the solicitation of proxies in respect of the 2025 Annual Meeting and other relevant materials will be filed with the SEC when they become available. These documents are or will be available free of charge at the SEC's website at www.sec.gov.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250310043042/en/

    Media:

    Caroline Monahan

    843-740-2068

    [email protected]

    Kara Brickman / Greg Klassen

    Joele Frank, Wilkinson Brimmer Katcher

    212-355-4449

    Investors:

    John E. Nypaver, Jr.

    843-740-2002

    [email protected]

    Get the next $NGVT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NGVT

    DatePrice TargetRatingAnalyst
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    8/7/2024$58.00Market Perform → Market Outperform
    CJS Securities
    4/22/2024$52.00 → $62.00Hold → Buy
    Jefferies
    11/6/2023$49.00Market Outperform → Market Perform
    CJS Securities
    10/3/2023$62.00 → $53.00Buy → Hold
    Loop Capital
    8/7/2023$71.00 → $60.00Outperform → Market Perform
    BMO Capital Markets
    7/27/2023$64.00 → $75.00Hold → Buy
    Loop Capital
    5/5/2023$92.00 → $64.00Buy → Hold
    Loop Capital
    More analyst ratings

    $NGVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Ingevity reports first quarter 2025 financial results

      HIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash

      5/5/25 4:15:00 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity announces dates for first-quarter 2025 earnings release and webcast

      Ingevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025. The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through M

      4/24/25 9:00:00 AM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders

      Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote "FOR" ONLY Ingevity's Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders Ingevity Corporation (NYSE:NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meet

      3/20/25 5:34:00 PM ET
      $NGVT
      Major Chemicals
      Industrials

    $NGVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

      SC 13G/A - Ingevity Corp (0001653477) (Subject)

      11/12/24 3:54:24 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

      SC 13G/A - Ingevity Corp (0001653477) (Subject)

      11/4/24 11:52:25 AM ET
      $NGVT
      Major Chemicals
      Industrials
    • SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

      SC 13D/A - Ingevity Corp (0001653477) (Subject)

      2/28/24 5:30:32 PM ET
      $NGVT
      Major Chemicals
      Industrials

    $NGVT
    SEC Filings

    See more
    • SEC Form S-8 filed by Ingevity Corporation

      S-8 - Ingevity Corp (0001653477) (Filer)

      5/7/25 4:16:03 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Ingevity Corporation

      S-8 POS - Ingevity Corp (0001653477) (Filer)

      5/7/25 4:15:57 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • SEC Form 10-Q filed by Ingevity Corporation

      10-Q - Ingevity Corp (0001653477) (Filer)

      5/6/25 4:24:35 PM ET
      $NGVT
      Major Chemicals
      Industrials

    $NGVT
    Financials

    Live finance-specific insights

    See more
    • Ingevity reports first quarter 2025 financial results

      HIGHLIGHTS: Net sales of $284.0 million, down 17% compared to prior year, primarily due to repositioning actions in Performance Chemicals, which included the exit of certain lower-margin end markets Net income of $20.5 million and diluted earnings per share (EPS) of $0.56 reflects before-tax special charges of $20.2 million; adjusted earnings of $36.4 million and diluted adjusted EPS of $0.99 Adjusted EBITDA of $91.3 million increased 23% and adjusted EBITDA margin improved to 32.1% due primarily to the successful execution of repositioning actions in Performance Chemicals and continued strong profitability in Performance Materials Operating cash flow of $25.4 million with free cash

      5/5/25 4:15:00 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity announces dates for first-quarter 2025 earnings release and webcast

      Ingevity Corporation (NYSE:NGVT) announced today that it will release its first-quarter 2025 earnings after the stock market close on Monday, May 5, 2025. The company will host a live webcast on Tuesday, May 6, at 9:00 a.m. (Eastern) to discuss first-quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 815699. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on May 6, 2025, through M

      4/24/25 9:00:00 AM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity reports fourth quarter and full year 2024 financial results

      Fourth Quarter: Net sales of $298.8 million decreased 20% compared to prior year primarily due to repositioning actions in the Performance Chemicals segment that resulted in the exit of lower-margin end markets Net income of $16.6 million and diluted earnings per share (EPS) of $0.46, including pre-tax restructuring charges of $23.4 million; adjusted earnings of $34.7 million and diluted adjusted EPS of $0.95 Adjusted EBITDA of $80.6 million and adjusted EBITDA margin of 27.0% Operating cash flow of $64.5 million and free cash flow of $39.6 million, which included the second and final $50.0 million installment of a termination fee for a long-term crude tall oil (CTO) supply agreemen

      2/18/25 4:15:00 PM ET
      $NGVT
      Major Chemicals
      Industrials

    $NGVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Blackwell Jean was granted 4,057 shares, increasing direct ownership by 145% to 6,857 units (SEC Form 4)

      4 - Ingevity Corp (0001653477) (Issuer)

      5/5/25 6:42:08 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Director Fernandez-Moreno Luis M was granted 4,057 shares, increasing direct ownership by 8% to 53,105 units (SEC Form 4)

      4 - Ingevity Corp (0001653477) (Issuer)

      5/5/25 6:38:06 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Director Lynch Frederick J was granted 4,057 shares, increasing direct ownership by 18% to 26,359 units (SEC Form 4)

      4 - Ingevity Corp (0001653477) (Issuer)

      5/5/25 6:33:42 PM ET
      $NGVT
      Major Chemicals
      Industrials

    $NGVT
    Leadership Updates

    Live Leadership Updates

    See more
    • Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders

      Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote "FOR" ONLY Ingevity's Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders Ingevity Corporation (NYSE:NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meet

      3/20/25 5:34:00 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity announces appointment of David H. Li as president and CEO

      Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity's board. This press release features multimedia. View the full release here: https://www.businesswir

      3/10/25 4:15:00 PM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity Highlights Significant Momentum on Actions Underway to Drive Improved Performance and Value Creation

      Delivered Record Year in Performance Materials and Strategic Repositioning in Performance Chemicals Is Already Demonstrating Results Business Portfolio Review Is Progressing with Recently Announced Strategic Alternatives Process for Industrial Specialties Product Line and Evaluation of Additional Portfolio and Cost Reduction Actions Ongoing Provides Information About Engagement with Vision One Ingevity Corporation (NYSE:NGVT) today issued the following letter to stockholders in response to the presentation issued by Vision One Management Partners ("Vision One") earlier today: Dear Ingevity Stockholders, The Ingevity Board of Directors and leadership team are committed to taking ag

      2/25/25 4:21:00 PM ET
      $NGVT
      Major Chemicals
      Industrials

    $NGVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ingevity upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously

      2/26/25 7:15:06 AM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity upgraded by CJS Securities with a new price target

      CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00

      8/7/24 9:18:13 AM ET
      $NGVT
      Major Chemicals
      Industrials
    • Ingevity upgraded by Jefferies with a new price target

      Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously

      4/22/24 7:39:26 AM ET
      $NGVT
      Major Chemicals
      Industrials